Non-members: Click here to review a complimentary excerpt from "Pharma Social Media Listening: Adverse Event Reporting and Program Approval Process."
In an era of burgeoning social media websites, organizations across industry sectors are turning to social media listening as an effective way to capture consumer insights. Online disease state discussion among patients, physicians, caregivers and other key customer groups is flourishing. This is causing savvy healthcare companies to launch innovative Social Media Listening programs to capture critical market insights. For the pharmaceutical sector, social media listening can fill in critical business knowledge gaps around patient adherence, brand awareness, and therapeutic area/disease state perspectives.
Best Practices, LLC conducted this study to help healthcare companies better understand current industry approaches to issues surrounding the approval of Social Media Listening (SML) projects, and the concerns and relevance of Adverse Event reporting associated with SML projects. The study delivers crucial benchmarks and qualitative insights from industry-leading companies on approval processes, and Adverse Events reporting and management. Market research, digital/social media and marketing leaders can use this research to compare and enhance their Social Media Listening programs.
- Gaining Social Media Listening Approval
- Adverse Events Management & Compliance
- Innovative Strategies & Tactics for Winning Listening Approval
SAMPLE KEY METRICS
SAMPLE KEY FINDING
- Which Functions Primarily Leads the Social Media Listening (SML) Program Operations
- Frequency of Approvals Gained by SML Teams for Listening Activities
- Importance of Adverse Events (AE) Management in Establishing Listening Programs
- Use of Metrics to Track AE
- Steps Taken to Ensure AE Monitoring & Reporting Compliance
- Number of AE Encountered
- Top Listening Benefits Involve Rapid Project Insights: Primary Listening benefits include: rapid snapshots on brand awareness & loyalty, patient adherence trends, patient journey mapping, sentiment analysis, issues and objection handling (for physicians), misinformation levels, and "picking out cherries" of a qualitative nature to share back with brand leaders.
Fifteen Digital & Social Marketing and Market Research leaders at 13 large global healthcare organizations participated in this study via deep-dive interviews. Six of the top 10 largest pharmaceutical organizations are represented in this research, and more than half of all respondents work at the director level or above.